Drug Pipeline

Tipifarnib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06540963 Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma Neuroblastoma Recruiting
NCT04284774 Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders… Malignant Solid Neoplasm Active, Not Recruiting
NCT03155620 Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed… Advanced Malignant Solid Neoplasm Active, Not Recruiting
Sponsors Running Tipifarnib Trials
National Cancer Institute (NCI) (2) Giselle Sholler (1)
Disease Areas
Glioma (2) Non-Hodgkin Lymphoma (2) Sarcoma (2) Melanoma (1)
Get alerts when Tipifarnib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free